Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
23
|
pubmed:dateCreated |
1990-1-16
|
pubmed:abstractText |
The 5-lipoxygenase inhibitor REV-5901 [alpha-pentyl-3-(2-quinolinylmethoxy)benzene-methanol] was evaluated for effects on mediator release in vitro from fragmented guinea-pig and human lung. In guinea-pig lung, REV-5901 inhibited the antigen-induced release of immunoreactive leukotriene D4 (iLTD4) with an IC50 of 9.6 +/- 2.9 microM and immunoreactive leukotriene B4 (iLTB4) with an IC50 of 13.5 +/- 2.2 microM. REV-5901 also inhibited the calcium ionophore-induced release of immunoreactive leukotrienes from human lung in vitro with IC50 values of 11.7 +/- 2.2 MicroM versus peptide leukotrienes and 10.0 +/- 1.1 microM versus iLTB4. The inhibition of release of iLTD4 and iLTB4 with similar IC50 values suggests that REV-5901 acts by inhibiting 5-lipoxygenase in this system. At concentrations as high as 50 microM, REV-5901 did not inhibit the release of thromboxane B2 (TxB2), 6-keto-prostaglandin-F1 alpha (6-keto-PGF1 alpha), or histamine from either lung. The lack of effect on TxB2 and 6-keto-PGF1 alpha indicates that REV-5901 did not inhibit phospholipase A2, cyclooxygenase, or thromboxane synthetase. Inhibition of leukotriene release by REV-5901 could not be reversed by washing. Among various 5-lipoxygenase inhibitors, the order of potency for inhibition of iLTD4 release from guinea-pig lung was AA-861 greater than REV-5901 greater than phenidone greater than nafazatrom greater than NDGA greater than BW755C. These findings suggest that REV-5901 is a selective and relatively potent inhibitor of leukotriene release from lung tissue in vitro.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcimycin,
http://linkedlifedata.com/resource/pubmed/chemical/Histamine,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyquinolines,
http://linkedlifedata.com/resource/pubmed/chemical/Leukotriene B4,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin-Endoperoxide Synthases,
http://linkedlifedata.com/resource/pubmed/chemical/Quinolines,
http://linkedlifedata.com/resource/pubmed/chemical/SRS-A,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboxane B2,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-pentyl-3-(2-quinolinylmethoxy)...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0006-2952
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4183-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:2557041-Animals,
pubmed-meshheading:2557041-Calcimycin,
pubmed-meshheading:2557041-Culture Techniques,
pubmed-meshheading:2557041-Drug Interactions,
pubmed-meshheading:2557041-Guinea Pigs,
pubmed-meshheading:2557041-Histamine,
pubmed-meshheading:2557041-Humans,
pubmed-meshheading:2557041-Hydroxyquinolines,
pubmed-meshheading:2557041-Leukotriene B4,
pubmed-meshheading:2557041-Lipoxygenase Inhibitors,
pubmed-meshheading:2557041-Lung,
pubmed-meshheading:2557041-Male,
pubmed-meshheading:2557041-Prostaglandin-Endoperoxide Synthases,
pubmed-meshheading:2557041-Quinolines,
pubmed-meshheading:2557041-SRS-A,
pubmed-meshheading:2557041-Thromboxane B2,
pubmed-meshheading:2557041-Time Factors
|
pubmed:year |
1989
|
pubmed:articleTitle |
Inhibition by REV-5901 of leukotriene release from guinea-pig and human lung tissue in vitro.
|
pubmed:affiliation |
Department of Pharmacology, ICI Pharmaceuticals, Wilmington, DE 19897.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|